Form D · Pharmaceuticals
Rhythm Holding Company, LLC
Boston, MA · CIK 0001581617
Offering snapshot reported Jul 30, 2013 · SEC filing
- Reported sold
- $11M Offering amount: $11M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 16, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2013 | Initial | $11,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-200425
Source: Form D, filed Jul 30, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christian De La Tour | Director |
| Keith Gottesdiener | Director, Executive |
| Bart Henderson | Executive |
| Vaughn M. Kailian | Director |
| Edward Mathers | Director |
| Lou Tartaglia | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
855 Boylston Street
Boston, MA, 02116
Boston, MA, 02116